Hansen, Mueller Industries director, sells $105,710 in stock
Investing.com - BMO Capital has raised its price target on Raymond James (NYSE:RJF) to $182.00 from $180.00 while maintaining a Market Perform rating on the stock. The financial services firm, currently valued at $35.8 billion, trades at a P/E ratio of 13.73. According to InvestingPro data, the stock appears undervalued based on its Fair Value analysis.
The price target adjustment follows Raymond James’ fourth-quarter 2025 earnings report, which showed earnings per share of $3.12, exceeding BMO’s estimate of $3.10 and consensus expectations of $2.77. InvestingPro data reveals that 8 analysts have revised their earnings upwards for the upcoming period, suggesting growing confidence in the company’s outlook.
Transactional revenue and investment banking division (IBD) performance both surpassed expectations, with other transactional revenue providing a 4-cent tailwind versus consensus estimates.
The investment banking division’s outperformance was driven by debt capital markets (DCM), which contributed a 6-cent tailwind, and advisory services, which added a 1-cent tailwind to earnings.
BMO also noted that Raymond James saw sequential increases in Private Client Group (PCG) client assets, sweep balances, and net new assets, with net new assets growing at a 5.0% rate, though adjusted compensation and benefits represented a 5-cent headwind.
In other recent news, Raymond James Financial Inc . reported impressive fourth-quarter earnings for fiscal year 2025, surpassing analyst expectations. The company achieved an adjusted earnings per share (EPS) of $3.11, well above the projected $2.82. Additionally, Raymond James outperformed revenue forecasts, reporting $3.73 billion compared to the anticipated $3.64 billion. In another development, Citizens has raised its price target for Raymond James to $190.00 from $185.00, while maintaining a Market Outperform rating. The firm also increased its fiscal year 2026 earnings per share estimate to $12.55, positioning its forecast 7% above the current consensus estimate. These recent developments reflect positively on Raymond James’ growth outlook and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
